On September 17, 2019 Exicure, Inc. (Nasdaq: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA) constructs, reported that its chief operating officer, Dr. Matthias Schroff, will give a company presentation titled, "Multitargeting Spherical Nucleic Acids: Advantages & Applications," on Wednesday, September 18, 2019 at 11:40 am GMT at the 2019 International Oligonucleotide and Peptide Conference (Press release, Exicure, SEP 17, 2019, View Source [SID1234539589]). The presentation will be made in the Caplus Room of the Ramada Plaza Hotel in Milan.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!